Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02562924Completed
Randomised, open-label trial in chronic rhinosinusitis with nasal polyposis (CRSwNP) (3 arms), sponsored by University of Vermont Medical Center. Primary endpoint: Change in Lund-Kennedy Endoscopic Scores at 119 days. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02562924.